As a result of this process, reducing PVL to 2.1%, CD8/CD25 to 5%, CD8/HLA-DR to 19% and β2M to 1.7 μg/mL increased the sensitivity of the model identifying 88% of the patients with HAM. This evidence concerns the gene B2M and tropical spastic paraparesis.